MedPath

A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer

Phase 3
Completed
Conditions
Gastric Cancer
Registration Number
NCT00142350
Lead Sponsor
Japan Clinical Oncology Group
Brief Summary

To investigate the superiority of a combination of irinotecan and cisplatin and the non-inferiority of S-1 compared to continuous infusion of 5-FU in advanced gastric cancer

Detailed Description

From the results of our previous phase III study (JCOG9205), continuous infusion of 5-fluorouracil has remained to be a control arm of this study. This study investigates the superiority of a combination of irinotecan plus cisplatin and non-inferiority of S-1, a oral fluoropyrimidine, compared to continuous infusion of 5-fluorouracil at the point of overall survival, and the planned number of enrolled patients is 690 (230/arm).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
690
Inclusion Criteria
  1. unresectable or recurrent histologically proved gastric cancer
  2. adequate oral intake
  3. age 20 or older and 75 or younger
  4. Performance Status (ECOG):0, 1, 2
  5. measurable or unmeasurable lesions
  6. preserved organ functions
  7. no severe medical condition
  8. no prior chemotherapy for gastric cancer
  9. written informed consent
Exclusion Criteria
  1. patient with marked infection or inflammation
  2. patient with severe peritoneal metastasis
  3. patient with massive pleural effusion
  4. patient with metastasis to CNS
  5. patient with diarrhea 4 or more times per day
  6. patient severe medical condition
  7. patient with other concurrent malignancy affecting on survival or adverse events
  8. pregnant or nursing patient or with intent to bear baby
  9. patient evaluated to be inadequate by a attending doctor
  10. patient requiring nutritional support

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
overall survival
Secondary Outcome Measures
NameTimeMethod
time to treatment failure
incidences of adverse events
response rate
non-hospitalized survival

Trial Locations

Locations (34)

Aichi Cancer Center Hospital

🇯🇵

Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan

Hyogo Medical Center for Adults

🇯🇵

Akashi,Kitaouji-cho,13-70, Hyogo, Japan

Kyoto University Hospital

🇯🇵

Kyoto,Sakyo-ku,Syogoinkawara,54, Kyoto, Japan

Showa University School of Medicine

🇯🇵

Shinagawa-ku,Hatanodai,1-5-8, Tokyo, Japan

Cancer Institute Hospital

🇯🇵

Koto-ku,Ariake,3-10-6, Tokyo, Japan

Aomori Prefectural Central Hospital

🇯🇵

Higashitsukurimiti,2-1-1,Aomori, Aomori, Japan

Yokohama City University Medical Center

🇯🇵

Yokohama,Minami-ku,Urafunecho,4-57, Kanagawa, Japan

Asahi General Hospital

🇯🇵

I-1326,Asahi, Chiba, Japan

Nagoya Medical Center

🇯🇵

Nagoya,Naka-ku,Sannomaru,4-1-1, Aichi, Japan

Aichi Cancer Center,Aichi Hospital

🇯🇵

Okazaki,Kake-machi,Kuriyado,18, Aichi, Japan

Chiba Cancer Center Hospital

🇯🇵

Chiba,Chuo-ku,Nitona-cho,666-2, Chiba, Japan

Kyushu University Hospital

🇯🇵

Fukuoka,Higashi-ku,Maidashi,3-1-1, Fukuoka, Japan

National Kyushu Cancer Center

🇯🇵

Fukuoka,Minami-ku,Notame,3-1-1, Fukuoka, Japan

National Hospital Organization Shikoku Cancer Center

🇯🇵

Matsuyama,Horinouchi,13, Ehime, Japan

Iwate Prefectural Central Hospital

🇯🇵

Morioka,Ueda,1-4-1, Iwate, Japan

Hokkaido University Hospital

🇯🇵

North-14 West-5 Kita-ku,Sapporo, Hokkaido, Japan

Federation of national public service personnel mutual aid associations Tonan Hospital

🇯🇵

kita 1 nishi 6,Chuo-ku,Sapporo, Hokkaido, Japan

Kobe University Graduate School of Medicine

🇯🇵

Kobe,Chuo-ku,Kusunoki-cho,7-5-2, Hyogo, Japan

Kitasato University East Hospital

🇯🇵

Sagamihara,Asamizodai,2-1-1, Kanagawa, Japan

Ibaraki Kenritsu Chuo Hospital & Cancer Center

🇯🇵

Nishi-ibarakigun,Tomobemachi,Koibuchi,6528, Ibaraki, Japan

Yokohama Mucipical Citizen's Hospital

🇯🇵

Yokohama,Hodogaya-ku,Okazawa-cho,56, Kanagawa, Japan

Kanagawa Cancer Center

🇯🇵

Yokohama,Asahi-ku,Nakao,1-1-2, Kanagawa, Japan

Kochi Health Science Center

🇯🇵

Kochi,Ike,2125-1, Kochi, Japan

Kumamoto Regional Medical Center Hospital

🇯🇵

Kumamoto,Honjo,5-16-10, Kumamoto, Japan

Tohoku University Hospital

🇯🇵

Sendai,Aoba-ku,Seiryo-machi,1-1, Miyagi, Japan

Saku Central Hospital

🇯🇵

Saku,Usuda,197, Nagano, Japan

Saitama Medical School Hospital

🇯🇵

Iruma-gun,Moroyama-machi,Morohongo,38, Saitama, Japan

Saitama Cancer Center

🇯🇵

Kita-adachi,Ina,Komuro,818, Saitama, Japan

Div. of Gastrointestinal Oncology, Shizuoka Cancer Center

🇯🇵

Sunto-gun, Nagaizumi-cho, Shimonagakubo,1007, Shizuoka, Japan

Tochigi Cancer Center

🇯🇵

Utsunomiya,Yohnan,4-9-13, Tochigi, Japan

National Cancer Center Hospital

🇯🇵

Chuo-ku,Tsukiji,5-1-1, Tokyo, Japan

National Cancer Center Hospital East

🇯🇵

Kashiwa,Kashiwanoha,6-5-1, Chiba, Japan

Osaka Medical College

🇯🇵

Takatsuki,Daigakucho,2-7, Osaka, Japan

Yamagata Prefectural Central Hospital

🇯🇵

Yamagata,Aoyagi,1800, Yamagata, Japan

© Copyright 2025. All Rights Reserved by MedPath